Nogapendekin alfa inbakicept (NAI) + Nivolumab + Ipilimumab + Carboplatin + Nab-paclitaxel

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung CancerNCT03520686IBRXPhase 3Terminated2025-10-13Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.